SCHEMBL5396306

SCHEMBL5396306

C#CCCOc1ccc(C(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
LSS P48449 2/20 0.48
GAA P10253 1/20 0.47
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
PPARG P37231 3/20 0.45
PPARA Q07869 3/20 0.45
HRH3 Q9Y5N1 1/20 0.45
PPARD Q03181 1/20 0.45
NR4A2 P43354 1/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
THRB P10828 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAOB P27338 2/20 0.44
PARP10 Q53GL7 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561598 0.92 GAA (0.54) LMNAGAAPPARAALDH1A1NPSR1
SCHEMBL387869 0.87 CYP1A2 (0.46) LMNAGAAHRH3ALDH1A1L3MBTL1
SCHEMBL5385295 0.86 GAA (0.66) LMNASMN1; SMN2GAAPPARGPPARA
SCHEMBL16364112 0.84 CYP19A1 (0.53) LMNASMN1; SMN2LSSNR4A2ALDH1A1
SCHEMBL25960510 0.82 GAA (0.45) LMNASMN1; SMN2GAAPPARGPPARA
SCHEMBL16561604 0.82 L3MBTL1 (0.47) GAAALDH1A1MAPTL3MBTL1MAOB
SCHEMBL16561562 0.81 THRA (0.52) LMNAGAAPPARAALDH1A1NPSR1
SCHEMBL25375924 0.80 PKM (0.62) NR4A2ALDH1A1L3MBTL1HTT
SCHEMBL1811815 0.80 GAA (0.72) LMNASMN1; SMN2LSSGAAHRH2
SCHEMBL31747443 0.79 PARP10 (0.62) HRH3ALDH1A1MAOBPARP10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed
EP-1392637-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2004-03-03 EP disclosed
WO-2002100813-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA LMNA 3747/4885SMN1; SMN2 4742/4885LSS 2302/4885
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors PPARG, NCOA4, PPARA LMNA 4004/4885SMN1; SMN2 4782/4885LSS 2207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.